OPERATING ROOM
that demonstrated when compared to aver- age overall room turn times there was only the four-minute overall variance.” Larinda Becker, Healthcare Marketing, Diversey, said her company’s product, the MoonBeam3, “is fast, effective, portable and affordable. With 3- minute cycles, the 39-pound unit can be effectively deployed by any staff member. Its articulating arms enable the user to optimize dose coverage on both horizontal and vertical surfaces. MoonBeam can be easily moved around the facility and requires minimal storage space. The product cycle for the MoonBeam3 is 3 minutes. We recom- mend dosing two sides of the room and the bathroom for each patient room. In general, the system can be “doubled” up to run simultaneous cycles in the patient room and a cycle in the bathroom while the staff member is fi nishing the room. It is estimated that a patient room can be done in as little as 12 minutes with a single unit (includes placement of the device and cycle times) or in as little 7 minutes with two units.
“Most importantly, it can be acquired and operated at a fraction of the cost of other units,” Becker continued. “Operational
Diversy’s MoonBeam3
leases (similar to renting), allow payments to be considered operational expenses, and allow the asset to stay off the balance sheet. In many cases, due to capital and time requirements, UV-C disinfection is being limited to a small sampling of rooms; how- ever, with the recent launch of operational leases, requiring no capital expenditures and newer technologies that have faster cycle times and lower acquisition and use cost, UV-C can now be used more broadly across facilities. Increased deployment may also drive patient satisfaction by demon- strating a fi rm commitment to preventing infection. Programs are available for as little as $1000/month, and include the device, service and UV-C bulbs.
Gunner Lyslo, Founder and CEO, Sur- facide, said his technology “addresses the role of shadows given our multiple emitter approach. Published data indicate that UV is a direct line of sight technol- ogy. When using three emitters during a single treatment cycle, most surfaces are within the direct line of sight and ef- fectively treated. Single emitter systems should require frequent repositioning and extended run times. Surfacide’s au- tomated system provides shorter cycle times and increased staff productivity without repositioning. istance is critical to V- effi cacy as the distance increases, less energy is delivered to surfaces,” Lyslo continued. “Surfacide positions multiple emitters closer to surfaces, delivering more energy throughout the room in a single cycle. The paradigm shift in using UV Technology is it contemplates simple laws of physics vs. the chemistry of chemical based dis- infectants. This is very easily explained through the Inverse Square Law that can be summarized in the following: as the distance from the emitting source is doubled, the energy is not reduced by 50 percent, it is reduced to 25 percent.
Visible on all skin tones
XL Prep Resistant Ink is now available in red
[XL Ink] helps us comply with national patient safety guidelines.
It assures
that we can verify the mark after scrub.
- B.P., Materials Manager
Prep Resistant Demo :
www.bit.ly/XL-Demo viscotcs@viscot.com •
www.viscot.com • 800.221.0658
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
